Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1996 May;3(3):321–325. doi: 10.1128/cdli.3.3.321-325.1996

Immune responses to the R4 protein antigen of group B streptococci and its relationship to other streptococcal R4 proteins.

E L Fasola 1, A E Flores 1, P Ferrieri 1
PMCID: PMC170340  PMID: 8705677

Abstract

The R antigen, a trypsin-resistant protein observed in group A, C, F, G, and L streptococci, has also been found in group B streptococci (GBS). Although four species of the R antigen have been described for GBS, the R4 protein is the most prevalent in GBS isolates recovered from humans. This study examined the prevalence of antibodies against the R4 antigen by Western blot (immunoblot) (WB) in sera from 40 mothers colonized with GBS serotype II and III and from 26 noncolonized mothers; 92.5% of the colonized mothers had anti-R4 antibodies, compared with 54% of the noncolonized mothers (P < 0.001). Findings of antibodies in neonatal cord sera (n = 14) were concordant with maternal results by WB analysis for 71% of mother-infant pairs colonized with serotype II and for 57% of pairs colonized with serotype III. Of mothers known to be colonized with type II/R4 or III/R4, 100% (n = 12) had antibody against R4 by WB. This study also evaluated the prevalence of antibody to the GBS R4 antigen in 48 sera from individuals with high and low group A streptococcal anti-DNase B titers. Of those individuals with an anti-DNase B titer of > 640, 64% had a positive WB for anti-R4 antibody, compared with 30% of individuals with low anti-DNase B titers (P < 0.05). The R4 antigen of GBS had immunologic identity to the R4 antigen of group A streptococci. Overall, the findings suggested that antibodies to the streptococcal R4 antigen were commonly present in GBS-colonized mothers and that transplacental passage of these antibodies occurred. The presence of antibody to R4 in non-GBS-colonized individuals may be due to immunologic responses to past exposure to the R antigen present in GBS or other streptococcal groups.

Full Text

The Full Text of this article is available as a PDF (296.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker C. J., Kasper D. L. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med. 1976 Apr 1;294(14):753–756. doi: 10.1056/NEJM197604012941404. [DOI] [PubMed] [Google Scholar]
  2. Ferrieri P. Neonatal susceptibility and immunity to major bacterial pathogens. Rev Infect Dis. 1990 May-Jun;12 (Suppl 4):S394–S400. doi: 10.1093/clinids/12.supplement_4.s394. [DOI] [PubMed] [Google Scholar]
  3. Ferrieri P. Surface-localized protein antigens of group B streptococci. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 2):S363–S366. doi: 10.1093/cid/10.supplement_2.s363. [DOI] [PubMed] [Google Scholar]
  4. Flores A. E., Ferrieri P. Molecular species of R-protein antigens produced by clinical isolates of group B streptococci. J Clin Microbiol. 1989 May;27(5):1050–1054. doi: 10.1128/jcm.27.5.1050-1054.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Flores A. E., Nelson J. A., Wu X. Y., Ferrieri P. Antibody profiles to the group B streptococcal beta antigen in maternal and infant paired sera. APMIS. 1993 Jan;101(1):41–49. doi: 10.1111/j.1699-0463.1993.tb00079.x. [DOI] [PubMed] [Google Scholar]
  6. Johnson D. R., Ferrieri P. Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes. J Clin Microbiol. 1984 Apr;19(4):506–510. doi: 10.1128/jcm.19.4.506-510.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lancefield R. C., Freimer E. H. Type-specific polysaccharide antigens of group B streptococci. J Hyg (Lond) 1966 Jun;64(2):191–203. doi: 10.1017/s0022172400040456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lancefield R. C., McCarty M., Everly W. N. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J Exp Med. 1975 Jul 1;142(1):165–179. doi: 10.1084/jem.142.1.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lindén V., Christensen K. K., Christensen P. Correlation between low levels of maternal IgG antibodies to R protein and neonatal septicemia with group B streptococci carrying R protein. Int Arch Allergy Appl Immunol. 1983;71(2):168–172. doi: 10.1159/000233382. [DOI] [PubMed] [Google Scholar]
  10. Lindén V. Mouse-protective effect of rabbit anti-R-protein antibodies against group B streptococci type II carrying R-protein. Lack of effect on type III carrying R-protein. Acta Pathol Microbiol Immunol Scand B. 1983 Apr;91(2):145–151. doi: 10.1111/j.1699-0463.1983.tb00024.x. [DOI] [PubMed] [Google Scholar]
  11. Michel J. L., Madoff L. C., Kling D. E., Kasper D. L., Ausubel F. M. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity. Infect Immun. 1991 Jun;59(6):2023–2028. doi: 10.1128/iai.59.6.2023-2028.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Stålhammar-Carlemalm M., Stenberg L., Lindahl G. Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J Exp Med. 1993 Jun 1;177(6):1593–1603. doi: 10.1084/jem.177.6.1593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Valtonen M. V., Kasper D. L., Levy N. J. Isolation of a C (Ibc) protein from group B Streptococcus which elicits mouse protective antibody. Microb Pathog. 1986 Apr;1(2):191–204. doi: 10.1016/0882-4010(86)90021-5. [DOI] [PubMed] [Google Scholar]
  14. Wibawan I. W., Lämmler C. Distribution of B streptococcal type antigens among streptococci of serological groups B, G and L. Zentralbl Bakteriol. 1990 Sep;273(4):471–477. doi: 10.1016/s0934-8840(11)80454-8. [DOI] [PubMed] [Google Scholar]
  15. Wilkinson H. W. Comparison of streptococcal R antigens. Appl Microbiol. 1972 Oct;24(4):669–670. doi: 10.1128/am.24.4.669-670.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Zangwill K. M., Schuchat A., Wenger J. D. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ. 1992 Nov 20;41(6):25–32. [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES